Bjorn Stroier Larsen
Overview
Explore the profile of Bjorn Stroier Larsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Christiansen P, Larsen B, Hadad R, Nielsen O, Dominguez Vall-Lamora M, Prescott E, et al.
Heart Rhythm O2
. 2025 Jan;
5(7):427-434.
PMID: 39802887
Background: Nonsustained ventricular tachycardia (NSVT) is a common finding during cardiac evaluation and has been linked to increased mortality. While some studies report a sex difference, most data stem from...
2.
Larsen B, Biering-Sorensen T, Olsen F
Expert Rev Cardiovasc Ther
. 2024 Jun;
22(7):289-300.
PMID: 38943632
Introduction: Ischemic stroke is a leading cause of morbidity and mortality worldwide. Emerging evidence suggests that left atrial (LA) dysfunction could play a role in the pathophysiology of ischemic stroke,...
3.
Myhr K, Andres-Jensen L, Larsen B, Kunkel J, Kristensen C, Vejlstrup N, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Mar;
25(8):1109-1117.
PMID: 38469906
Aims: Cardiovascular diseases manifest differently in males and females, potentially influenced by inherent sex- and age-related differences in myocardial tissue composition. Such inherent differences are not well-established in the literature....
4.
Larsen B, Bertelsen L, Christensen H, Hadad R, Aplin M, Host N, et al.
Eur Heart J Cardiovasc Imaging
. 2023 Jan;
24(5):625-634.
PMID: 36691845
Aims: To evaluate the extent of left atrial (LA) fibrosis in patients with a recent stroke without atrial fibrillation and controls without established cardiovascular disease. Methods And Results: This prospectively...
5.
Hadad R, Akobe S, Weber P, Madsen C, Larsen B, Madsbad S, et al.
Sci Rep
. 2022 Oct;
12(1):18020.
PMID: 36289393
Autonomic imbalance reflected by higher resting heart rate and reduced parasympathetic tone may be driven by low-grade inflammation (LGI) and impaired glycemic control in type 2 diabetes mellitus (T2DM) and...
6.
Larsen B, Olsen F, Andersen D, Madsen C, Mogelvang R, Jensen G, et al.
J Am Heart Assoc
. 2022 Sep;
11(18):e027031.
PMID: 36073645
Background Left atrial (LA) volumes and emptying fraction in the general population may address structural and functional aspects of atrial cardiomyopathy associated with long-term risk of ischemic stroke in the...
7.
Larsen B, Aplin M, Host N, Dominguez H, Christensen H, Christensen L, et al.
BMJ Open
. 2022 May;
12(5):e061018.
PMID: 35545392
Introduction: Despite workup for the aetiology of ischaemic stroke, about 25% of cases remain unexplained. Paroxysmal atrial fibrillation is typically suspected but often not detected. Even if atrial fibrillation (AF)...
8.
Stavnem D, Hadad R, Larsen B, Nielsen O, Aplin Frederiksen M, Davidsen U, et al.
Cardiology
. 2021 Oct;
147(1):57-61.
PMID: 34662878
Background: In patients with atrial fibrillation (AF), the long-term prognosis of long electrocardiographic pauses in the ventricular action is not well studied. Methods: Consecutive Holter recordings in patients with AF...
9.
Larsen B, Aplin M, Nielsen O, Dominguez Vall-Lamora M, Host N, Kristiansen O, et al.
Heart Rhythm O2
. 2021 Aug;
2(3):231-238.
PMID: 34337573
Background: Excessive supraventricular ectopic activity (ESVEA), defined as ≥720 premature atrial contractions (PAC) per day or any runs of ≥20 PACs, has been proposed as a surrogate marker for paroxysmal...
10.
Rasmussen M, Kumarathurai P, Fabricius-Bjerre A, Larsen B, Dominguez H, Davidsen U, et al.
Ann Noninvasive Electrocardiol
. 2020 Apr;
25(5):e12751.
PMID: 32274894
Background: P-wave duration (P ) and P-wave area (P ) have been linked to risk of atrial fibrillation (AF), but they do not improve the efficacy of Framingham AF risk...